Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Autologous Umbilical Cord Blood----2件: 211, 294
2Blood sample----20件: 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299
3Bronchodilator Response----1件: 294
4Combination Product: lipid injectable emulsion with Fish oil1件: Fish oil---1件: 294
5Fish Oil1件: Fish oil---8件: 13, 46, 49, 66, 96, 260, 294, 299
6Hypersaline----1件: 294
7INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI----1件: 294
8INALOSSIN 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO----1件: 294
9Inhaled Nitric Oxide (iNO) use1件: Nitric Oxide1件: D00074 --1件: 294
10INOmax1件: Nitric Oxide1件: D00074 --3件: 85, 294, 299
11INOmax 800ppm mol/mol inhalatiegas1件: Nitric Oxide1件: D00074 --1件: 294
12Losec1件: Omeprazole1件: D00455 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬3件: 46, 225, 294
13Milrinone1件: Milrinone1件: D00417 2件: PDE3A,
PDE3B 💬		11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 294
14Neophyr 1000ppm mol/mol----1件: 294
15NITRIC OXIDE1件: Nitric Oxide1件: D00074 --7件: 85, 86, 88, 210, 251, 294, 299
16Omeprazol1件: Omeprazole1件: D00455 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 294
17Omeprazole1件: Omeprazole1件: D00455 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬14件: 6, 8, 21, 46, 51, 85, 96, 97, 225, 271, 282, 294, 298, 299
18Omeprazole rectally 1mg/kg1件: Omeprazole1件: D00455 2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 294
19OSSIDO DI AZOTO----1件: 294
20REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294
21Revatio 0.8mg/ml solution for injection----1件: 294
22Sildenafil1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301
23Sildenafil Oral Suspension1件: Sildenafil1件: D08514 1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294